Skip to main content
Djordje Atanackovic

Djordje Atanackovic, MD

Academic Office Information

About Me

Our goal is to develop novel immunotherapies for different types of solid tumors and hematologic malignancies with a focus on Multiple Myeloma. This includes antibody-based and cellular immunotherapies such as CAR T cells and TCR-transduced T cells. We have also developed a number of techniques for the detailed immunomonitoring of clinical trials with novel immunotherapeutic agents.

3i Bridge/Pillar: Cancer

Keywords: cancer immunotherapy, tumor immunology, CAR T cells, TCR-transduced T cells, monoclonal antibodies